Brown Ryan Edward 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Brown Ryan Edward
SVP, General Counsel
Transactions
- Tax Payment
Common Stock
2024-03-01$126.19/sh−269$33,945→ 27,827 total - Award
Common Stock
2024-03-01+6,000→ 33,827 total - Sale
Common Stock
2024-03-01$125.34/sh−2,000$250,680→ 31,827 total - Award
Stock Option (right to buy)
2024-03-01−12,500→ 12,500 totalExercise: $128.67From: 2025-03-01Exp: 2034-03-01→ Common Stock (12,500 underlying)
Footnotes (4)
- [F1]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020.
- [F2]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
- [F3]Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.
- [F4]Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.